XML 61 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Accrued Liabilities an Other Long-term Liabilities (Tables)
 12 Months Ended
Dec. 31, 2024
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]
Accrued liabilities consist of the following (in thousands):
As of December 31,
 20242023
Salaries and benefits$60,815 $52,250 
Incentive compensation59,445 37,992 
Operating lease liability-ST15,695 20,161 
Accrued professional fees3,167 2,803 
Field service corrective action(1)
32,844 30,281 
Italy medical device payback provision(2)
23,937 23,176 
Legal accrual3,425 1,874 
Accrued sales taxes4,449 6,748 
Warranties and returns4,094 3,682 
Deferred revenue30,358 31,640 
Accrued other taxes4,564 3,024 
Distribution fees16,548 13,049 
Accrued freight13,206 17,215 
Restructuring accrual9,945 3,568 
Foreign exchange contracts7,391 2,590 
Accrued audit fees4,395 5,492 
Defined benefit plan3,111 2,575 
Accrued interest667 1,431 
Other8,867 8,664 
 $306,923 $268,215 
_____________________________
(1) Primarily includes field corrective actions associated with certain products in connection with a 2021 Warning Letter (as defined below) received by Smiths Medical from the FDA following an inspection of Smiths Medical's Oakdale, Minnesota Facility (see Note 16: Commitments and Contingencies for further details).
(2) Related to potential payments associated with the IMDP (as defined below) as a result of 2015 legislation enacted requiring medical device companies to make payments to the Italian government based on regional expenditure ceilings (see Note 16: Commitments and Contingencies for further details).
As of December 31, 2024, certain accrued liability account balances that are part of a disposal group that met the criteria for assets held for sale during the fourth quarter of 2024 were presented as a separate line item "Liabilities held for sale" in our consolidated balance sheet (See Note 4:Assets Held For Sale).
Other Liabilities
Other long-term liabilities consist of the following (in thousands):
As of December 31,
 20242023
Operating lease liability-LT$40,777 $52,972 
Finance lease liability-LT2,332 1,954 
Deferred revenue9,045 10,585 
Benefits3,830 4,207 
Field service corrective action(1)
6,401 26,056 
Accrued rent618 841 
Other3,742 3,882 
 $66,745 $100,497 
_______________________________
(1)     Primarily related to field corrective actions associated with certain products in connection with a 2021 Warning Letter (as defined below) received by Smiths Medical from the FDA following an inspection of Smiths Medical's Oakdale, Minnesota Facility (see Note 16: Commitments and Contingencies for further details).